$ISTA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ISTA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ISTA PHARMACEUTICALS INC. Get notifications about new insider transactions in ISTA PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 13 2011 | ISTA | ISTA PHARMACEUTICA ... | LAPORTE KATHLEEN | Director | Buy | X | 1.41 | 1,615,385 | 2,277,693 | 8,561,041 | 6.9 M to 8.6 M (+23.26 %) |
Apr 13 2011 | ISTA | ISTA PHARMACEUTICA ... | CREDIT SUISSE AG/ | 10% Owner | Option Exercise | X | 1.41 | 1,615,385 | 2,277,693 | 0 | |
Apr 13 2011 | ISTA | ISTA PHARMACEUTICA ... | CREDIT SUISSE AG/ | 10% Owner | Option Exercise | P | 1.41 | 1,615,385 | 2,277,693 | 1,615,385 | |
Apr 13 2011 | ISTA | ISTA PHARMACEUTICA ... | CREDIT SUISSE AG/ | 10% Owner | Sell | S | 10.52 | 216,526 | 2,277,854 | 8,336,583 | 8.6 M to 8.3 M (-2.53 %) |
Apr 13 2011 | ISTA | ISTA PHARMACEUTICA ... | CREDIT SUISSE AG/ | 10% Owner | Buy | X | 1.41 | 1,615,385 | 2,277,693 | 8,553,109 | 6.9 M to 8.6 M (+23.28 %) |
Feb 10 2011 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP, Sales & Marketi ... | Sell | D | 7.48 | 1,388 | 10,382 | 91,569 | 93 K to 91.6 K (-1.49 %) |
Feb 10 2011 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Sell | D | 7.48 | 1,051 | 7,861 | 42,491 | 43.5 K to 42.5 K (-2.41 %) |
Feb 10 2011 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 7.48 | 3,332 | 24,923 | 413,440 | 416.8 K to 413.4 K (-0.80 %) |
Feb 10 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Sell | D | 7.48 | 1,104 | 8,258 | 65,338 | 66.4 K to 65.3 K (-1.66 %) |
Feb 10 2011 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Sell | D | 7.48 | 841 | 6,291 | 36,066 | 36.9 K to 36.1 K (-2.28 %) |
Feb 10 2011 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR and Corp. Fa ... | Sell | D | 7.48 | 841 | 6,291 | 41,002 | 41.8 K to 41 K (-2.01 %) |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 6.82 | 17,113 | 116,711 | 17,113 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 6.82 | 28,337 | 193,258 | 28,337 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Grant | A | 0.00 | 10,100 | 10 | 43,542 | 33.4 K to 43.5 K (+30.20 %) |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP, Sales & Marketi ... | Option Exercise | A | 6.82 | 26,629 | 181,610 | 26,629 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP, Sales & Marketi ... | Option Exercise | A | 6.82 | 23,371 | 159,390 | 23,371 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP, Sales & Marketi ... | Grant | A | 0.00 | 11,150 | 11 | 92,957 | 81.8 K to 93 K (+13.63 %) |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 6.82 | 8,609 | 58,713 | 8,609 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 6.82 | 29,641 | 202,152 | 29,641 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Grant | A | 0.00 | 8,500 | 9 | 53,484 | 45 K to 53.5 K (+18.90 %) |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | A | 6.82 | 21,396 | 145,921 | 21,396 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Option Exercise | A | 6.82 | 27,754 | 189,282 | 27,754 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Grant | A | 0.00 | 10,950 | 11 | 66,442 | 55.5 K to 66.4 K (+19.73 %) |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR and Corp. Fa ... | Option Exercise | A | 6.82 | 9,981 | 68,070 | 9,981 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR and Corp. Fa ... | Option Exercise | A | 6.82 | 28,269 | 192,795 | 28,269 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR and Corp. Fa ... | Grant | A | 0.00 | 8,500 | 9 | 41,843 | 33.3 K to 41.8 K (+25.49 %) |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Option Exercise | A | 6.82 | 8,879 | 60,555 | 8,879 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Option Exercise | A | 6.82 | 29,371 | 200,310 | 29,371 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Grant | A | 0.00 | 8,500 | 9 | 36,907 | 28.4 K to 36.9 K (+29.92 %) |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 6.82 | 145,798 | 994,342 | 145,798 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 6.82 | 17,852 | 121,751 | 17,852 | |
Feb 09 2011 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Grant | A | 0.00 | 36,350 | 36 | 442,458 | 406.1 K to 442.5 K (+8.95 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Sell | D | 6.15 | 578 | 3,555 | 28,407 | 29 K to 28.4 K (-1.99 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Sell | D | 6.15 | 841 | 5,172 | 28,985 | 29.8 K to 29 K (-2.82 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 6.15 | 2,187 | 13,450 | 409,440 | 411.6 K to 409.4 K (-0.53 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 6.15 | 3,440 | 21,156 | 411,627 | 415.1 K to 411.6 K (-0.83 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP, Sales & Marketi ... | Sell | D | 6.15 | 841 | 5,172 | 81,807 | 82.6 K to 81.8 K (-1.02 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP, Sales & Marketi ... | Sell | D | 6.15 | 1,756 | 10,799 | 82,648 | 84.4 K to 82.6 K (-2.08 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Sell | D | 6.15 | 736 | 4,526 | 33,442 | 34.2 K to 33.4 K (-2.15 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Sell | D | 6.15 | 841 | 5,172 | 34,178 | 35 K to 34.2 K (-2.40 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR and Corp. Fa ... | Sell | D | 6.15 | 662 | 4,071 | 34,184 | 34.8 K to 34.2 K (-1.90 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR and Corp. Fa ... | Sell | D | 6.15 | 841 | 5,172 | 34,846 | 35.7 K to 34.8 K (-2.36 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Sell | D | 6.15 | 736 | 4,526 | 56,438 | 57.2 K to 56.4 K (-1.29 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Sell | D | 6.15 | 946 | 5,818 | 57,174 | 58.1 K to 57.2 K (-1.63 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 6.20 | 3,332 | 20,658 | 406,108 | 409.4 K to 406.1 K (-0.81 %) |
Feb 02 2011 | ISTA | ISTA PHARMACEUTICA ... | Davis Glenn Eugene | VP Legal & Chief Co ... | Option Exercise | A | 5.44 | 13,500 | 73,440 | 87,000 | |
Feb 02 2011 | ISTA | ISTA PHARMACEUTICA ... | Davis Glenn Eugene | VP Legal & Chief Co ... | Grant | A | 0.00 | 3,000 | 3 | 19,333 | 16.3 K to 19.3 K (+18.37 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR and Corp. Fa ... | Sell | D | 6.20 | 841 | 5,214 | 33,343 | 34.2 K to 33.3 K (-2.46 %) |
Feb 07 2011 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | Chief Financial Off ... | Sell | D | 6.20 | 946 | 5,865 | 55,492 | 56.4 K to 55.5 K (-1.68 %) |
Feb 02 2011 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Grant | A | 0.00 | 2,833 | 3 | 11,793 | 9 K to 11.8 K (+31.62 %) |
Dec 20 2010 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Option Exercise | A | 4.58 | 7,250 | 33,205 | 7,250 | |
Dec 20 2010 | ISTA | ISTA PHARMACEUTICA ... | Drazba Brian G. | VP, Finance & CAO | Option Exercise | A | 4.58 | 12,750 | 58,395 | 12,750 | |
Dec 08 2010 | ISTA | ISTA PHARMACEUTICA ... | ROE WAYNE I | Director | Option Exercise | A | 4.58 | 20,000 | 91,600 | 20,000 | |
Dec 08 2010 | ISTA | ISTA PHARMACEUTICA ... | PERLMAN ANDREW J | Director | Option Exercise | A | 4.58 | 20,000 | 91,600 | 20,000 | |
Dec 08 2010 | ISTA | ISTA PHARMACEUTICA ... | MITCHELL DEAN J | Director | Option Exercise | A | 4.58 | 20,000 | 91,600 | 20,000 | |
Dec 08 2010 | ISTA | ISTA PHARMACEUTICA ... | MCGRAW BENJAMIN F III | Director | Option Exercise | A | 4.58 | 20,000 | 91,600 | 20,000 | |
Dec 08 2010 | ISTA | ISTA PHARMACEUTICA ... | LAPORTE KATHLEEN | Director | Option Exercise | A | 4.58 | 20,000 | 91,600 | 20,000 | |
Dec 08 2010 | ISTA | ISTA PHARMACEUTICA ... | HUTT PETER BARTON | Director | Option Exercise | A | 4.58 | 20,000 | 91,600 | 20,000 | |
Dec 08 2010 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 4.58 | 20,000 | 91,600 | 20,000 | |
Nov 19 2010 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Sell | D | 4.39 | 183 | 803 | 29,826 | 30 K to 29.8 K (-0.61 %) |
Feb 18 2010 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Sell | D | 3.96 | 229 | 907 | 30,009 | 30.2 K to 30 K (-0.76 %) |
Feb 18 2010 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Sell | D | 3.96 | 385 | 1,525 | 44,984 | 45.4 K to 45 K (-0.85 %) |
Feb 18 2010 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Sell | D | 3.96 | 559 | 2,214 | 35,019 | 35.6 K to 35 K (-1.57 %) |
Feb 18 2010 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Sell | D | 3.96 | 357 | 1,414 | 84,404 | 84.8 K to 84.4 K (-0.42 %) |
Feb 18 2010 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Sell | D | 3.96 | 394 | 1,560 | 35,687 | 36.1 K to 35.7 K (-1.09 %) |
Feb 18 2010 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Sell | D | 3.96 | 513 | 2,031 | 58,120 | 58.6 K to 58.1 K (-0.87 %) |
Feb 18 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 3.96 | 1,705 | 6,752 | 415,067 | 416.8 K to 415.1 K (-0.41 %) |
Feb 10 2010 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Sell | D | 3.59 | 733 | 2,631 | 45,369 | 46.1 K to 45.4 K (-1.59 %) |
Feb 10 2010 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Sell | D | 3.59 | 733 | 2,631 | 30,238 | 31 K to 30.2 K (-2.37 %) |
Feb 10 2010 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Sell | D | 3.59 | 916 | 3,288 | 35,578 | 36.5 K to 35.6 K (-2.51 %) |
Feb 10 2010 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Sell | D | 3.59 | 1,210 | 4,344 | 84,761 | 86 K to 84.8 K (-1.41 %) |
Feb 10 2010 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Sell | D | 3.59 | 733 | 2,631 | 36,081 | 36.8 K to 36.1 K (-1.99 %) |
Feb 10 2010 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Sell | D | 3.59 | 962 | 3,454 | 58,633 | 59.6 K to 58.6 K (-1.61 %) |
Feb 10 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 3.59 | 3,332 | 11,962 | 416,772 | 420.1 K to 416.8 K (-0.79 %) |
Feb 05 2010 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Sell | D | 3.60 | 879 | 3,164 | 46,102 | 47 K to 46.1 K (-1.87 %) |
Feb 05 2010 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Sell | D | 3.60 | 879 | 3,164 | 36,814 | 37.7 K to 36.8 K (-2.33 %) |
Feb 05 2010 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Sell | D | 3.60 | 989 | 3,560 | 59,595 | 60.6 K to 59.6 K (-1.63 %) |
Feb 05 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 3.60 | 3,995 | 14,382 | 420,104 | 424.1 K to 420.1 K (-0.94 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 3.63 | 11,296 | 41,004 | 11,296 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 3.63 | 30,704 | 111,456 | 30,704 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Grant | A | 0.00 | 8,000 | 8 | 36,494 | 28.5 K to 36.5 K (+28.08 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Sell | D | 3.63 | 769 | 2,791 | 28,494 | 29.3 K to 28.5 K (-2.63 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Option Exercise | A | 3.63 | 24,646 | 89,465 | 24,646 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Option Exercise | A | 3.63 | 36,704 | 133,236 | 36,704 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Grant | A | 0.00 | 16,700 | 17 | 85,971 | 69.3 K to 86 K (+24.11 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Sell | D | 3.63 | 879 | 3,191 | 69,271 | 70.2 K to 69.3 K (-1.25 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Option Exercise | A | 3.63 | 7,916 | 28,735 | 7,916 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Option Exercise | A | 3.63 | 30,084 | 109,205 | 30,084 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Grant | A | 0.00 | 8,000 | 8 | 37,693 | 29.7 K to 37.7 K (+26.94 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Sell | D | 3.63 | 692 | 2,512 | 29,693 | 30.4 K to 29.7 K (-2.28 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 3.63 | 123,789 | 449,354 | 123,789 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 3.63 | 39,861 | 144,695 | 39,861 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Grant | A | 0.00 | 36,350 | 36 | 424,099 | 387.7 K to 424.1 K (+9.37 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Sell | D | 3.63 | 2,286 | 8,298 | 387,749 | 390 K to 387.7 K (-0.59 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | A | 3.63 | 15,174 | 55,082 | 15,174 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | A | 3.63 | 31,826 | 115,528 | 31,826 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Grant | A | 0.00 | 9,000 | 9 | 60,584 | 51.6 K to 60.6 K (+17.45 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Sell | D | 3.63 | 769 | 2,791 | 51,584 | 52.4 K to 51.6 K (-1.47 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 3.63 | 7,291 | 26,466 | 7,291 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 3.63 | 27,709 | 100,584 | 27,709 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Grant | A | 0.00 | 8,000 | 8 | 46,981 | 39 K to 47 K (+20.52 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Sell | D | 3.63 | 769 | 2,791 | 38,981 | 39.8 K to 39 K (-1.93 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Option Exercise | A | 3.63 | 7,500 | 27,225 | 7,500 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Option Exercise | A | 3.63 | 28,500 | 103,455 | 28,500 | |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Grant | A | 0.00 | 8,000 | 8 | 30,971 | 23 K to 31 K (+34.83 %) |
Feb 04 2010 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Sell | D | 3.63 | 604 | 2,193 | 22,971 | 23.6 K to 23 K (-2.56 %) |
Dec 08 2009 | ISTA | ISTA PHARMACEUTICA ... | LAPORTE KATHLEEN | Director | Option Exercise | A | 4.72 | 20,000 | 94,400 | 20,000 | |
Dec 08 2009 | ISTA | ISTA PHARMACEUTICA ... | PERLMAN ANDREW J | Director | Option Exercise | A | 4.72 | 20,000 | 94,400 | 20,000 | |
Dec 08 2009 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Option Exercise | A | 4.72 | 20,000 | 94,400 | 20,000 | |
Dec 08 2009 | ISTA | ISTA PHARMACEUTICA ... | MITCHELL DEAN J | Director | Option Exercise | A | 4.72 | 20,000 | 94,400 | 20,000 | |
Dec 08 2009 | ISTA | ISTA PHARMACEUTICA ... | ROE WAYNE I | Director | Option Exercise | A | 4.72 | 20,000 | 94,400 | 20,000 | |
Dec 08 2009 | ISTA | ISTA PHARMACEUTICA ... | MCGRAW BENJAMIN F III | Director | Option Exercise | A | 4.72 | 20,000 | 94,400 | 20,000 | |
Dec 08 2009 | ISTA | ISTA PHARMACEUTICA ... | HUTT PETER BARTON | Director | Option Exercise | A | 4.72 | 20,000 | 94,400 | 20,000 | |
Aug 26 2009 | ISTA | ISTA PHARMACEUTICA ... | ROE WAYNE I | Director | Option Exercise | M | 3.49 | 32,500 | 113,425 | 0 | |
Aug 26 2009 | ISTA | ISTA PHARMACEUTICA ... | ROE WAYNE I | Director | Buy | M | 3.49 | 32,500 | 113,425 | 38,932 | 6.4 K to 38.9 K (+505.29 %) |
Jun 10 2009 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | Buy | P | 3.30 | 1,900 | 6,270 | 70,150 | 68.3 K to 70.2 K (+2.78 %) | |
Mar 02 2009 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Buy | P | 2.00 | 4,000 | 8,000 | 68,250 | 64.3 K to 68.3 K (+6.23 %) |
Feb 27 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 1.97 | 10,000 | 19,700 | 390,035 | 380 K to 390 K (+2.63 %) |
Feb 27 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 1.99 | 17,500 | 34,825 | 380,035 | 362.5 K to 380 K (+4.83 %) |
Feb 27 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 1.97 | 3,444 | 6,785 | 362,535 | 359.1 K to 362.5 K (+0.96 %) |
Feb 26 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 1.99 | 12,296 | 24,469 | 359,091 | 346.8 K to 359.1 K (+3.55 %) |
Feb 26 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 1.85 | 18,579 | 34,297 | 346,795 | 328.2 K to 346.8 K (+5.66 %) |
Feb 26 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Buy | P | 2.01 | 20,000 | 40,200 | 328,216 | 308.2 K to 328.2 K (+6.49 %) |
Feb 19 2009 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Sell | D | 1.82 | 223 | 406 | 23,575 | 23.8 K to 23.6 K (-0.94 %) |
Feb 19 2009 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Sell | D | 1.15 | 714 | 821 | 23,798 | 24.5 K to 23.8 K (-2.91 %) |
Feb 19 2009 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Sell | D | 1.82 | 384 | 699 | 30,385 | 30.8 K to 30.4 K (-1.25 %) |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 1.04 | 19,247 | 20,017 | 19,247 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Option Exercise | A | 1.04 | 22,753 | 23,663 | 22,753 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | GARRETT MARVIN J | Vice President, QC, ... | Grant | A | 0.00 | 8,000 | 8 | 29,263 | 21.3 K to 29.3 K (+37.62 %) |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Option Exercise | A | 1.04 | 28,115 | 29,240 | 28,115 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Option Exercise | A | 1.04 | 33,235 | 34,564 | 33,235 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Grant | A | 0.00 | 16,700 | 17 | 64,250 | 47.6 K to 64.3 K (+35.12 %) |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Option Exercise | A | 1.04 | 16,498 | 17,158 | 16,498 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Option Exercise | A | 1.04 | 19,502 | 20,282 | 19,502 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | McNamara Timothy | VP Clinical Researc ... | Grant | A | 0.00 | 8,000 | 8 | 24,512 | 16.5 K to 24.5 K (+48.45 %) |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 1.04 | 16,040 | 16,682 | 16,040 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Option Exercise | A | 1.04 | 18,960 | 19,718 | 18,960 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | MCMULLIN KIRK | VP, Operations | Grant | A | 0.00 | 8,000 | 8 | 39,750 | 31.8 K to 39.8 K (+25.20 %) |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Option Exercise | A | 1.04 | 17,412 | 18,108 | 17,412 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Option Exercise | A | 1.04 | 20,588 | 21,412 | 20,588 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | MCGINLEY KATHLEEN | VP, HR & Corp. Faci ... | Grant | A | 0.00 | 8,000 | 8 | 30,769 | 22.8 K to 30.8 K (+35.14 %) |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | A | 1.04 | 21,537 | 22,398 | 21,537 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Option Exercise | A | 1.04 | 25,463 | 26,482 | 25,463 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | SILVERNAIL LAUREN P | CFO | Grant | A | 0.00 | 9,000 | 9 | 52,353 | 43.4 K to 52.4 K (+20.76 %) |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 1.04 | 115,914 | 120,551 | 115,914 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Option Exercise | A | 1.04 | 47,736 | 49,645 | 47,736 | |
Feb 05 2009 | ISTA | ISTA PHARMACEUTICA ... | ANIDO VICENTE JR | President & CEO | Grant | A | 0.00 | 36,350 | 36 | 308,216 | 271.9 K to 308.2 K (+13.37 %) |
Dec 17 2008 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Buy | P | 0.80 | 6,225 | 4,980 | 117,532 | 111.3 K to 117.5 K (+5.59 %) |
Dec 17 2008 | ISTA | ISTA PHARMACEUTICA ... | WILLIAMS RICHARD C | Director | Buy | P | 0.82 | 200 | 164 | 111,307 | 111.1 K to 111.3 K (+0.18 %) |
Dec 17 2008 | ISTA | ISTA PHARMACEUTICA ... | MITRO THOMAS A | VP Sales & Marketin ... | Buy | P | 0.98 | 9,100 | 8,882 | 47,550 | 38.5 K to 47.6 K (+23.67 %) |